THE ANTIBODY SERIES 2024 Attendance Guide
FairJourney Biologics
Your trusted partner for innovative, end-to-end antibody services
Everything you need to know about the 4th edition of The Antibody Series
Overview Details
About
The Antibody Series is the fastest growing antibody conference of its kind. Started in 2021, in Porto, Portugal, the premier annual conference brings together international experts in the field of antibody discovery and development to discuss innovative topics and trends in the industry. Attendees benefit from knowledge exchange and opportunities to network with their peers in a scientifically stimulating environment, co-joined by +4,000 members online & on-demand.
Format & Attendance
If you have any questions about the conference, please contact us here.
Scientific Program
Wednesday 4th September:
Session: Antibodies in Close-up
Andrew Ward, Professor at the Scripps Research Institute: (Keynote) Deconstructing polyclonal antibody responses at the molecular level using cryoEM
Thomas Sharp, Associate Professor at the University of Bristol: Structural biology of complement initiation by the C1 complex
Thursday 5th September:
Session: Antibody Ensemble
George Georgiou, Dula D. Cockrell Centennial Chair and Professor at UT Austin: (Keynote) Understanding the Human Serological Antibody Repertoire
Rob de Jong, Director, Antibody Research and Technology at Genmab: Single molecule studies and applications of antibodies engineered to induce cell surface-restricted hexamerization
Matthew Romei, Senior Scientist, Dualitas Therapeutics, Inc: Antibody Architectures and Interfaces: Nature’s Guide to Biotherapeutic Engineering
Session: Antibody Protection
Dennis Burton, Chair and Professor in the Department of Immunology & Microbiology: How antibodies protect against viruses
Recommended by LinkedIn
Laura Walker, Head of Infectious Disease Biotherapeutic Discovery and Engineering at Moderna: mRNA-based delivery of engineered antibodies to combat SARS-CoV-2
Session: Computation and Design
Charlotte Deane, Professor of Structural Bioinformatics in the Department of Statistics at the University of Oxford: Moving the dial on computational antibody design
Jeffery Gray, Professor of Chemical and Biomolecular Engineering, Johns Hopkins University: Artificial Intelligence Tools for Antibody Engineering
Alex Lugovskoy, Co-founder and CEO of Diagonal Therapeutics: Computational epitope filtering of antibody repertoires enables reliable design of agonist antibodies to multimeric receptor complexes
Session: Scientific Briefings
Jannick Bendtsen, co-founder and CEO of PipeBio: An integrated bioinformatics platform for antibody discovery: Advancing data-driven decision making for therapeutic candidate selection
Speaker TBA: Lecture TBA
Friday 6th September
Session: New Targets and Technologies
Christoph Rader, CTO at Aethon Therapeutics: Creating and targeting synthetic neoepitopes on cancer cells
Marc Robillard, co-founder and CEO of Tagworks: Click-to-Release: on-target activation and off-target deactivation of antibody-based therapies
Sally Ward, Director of Translational Immunology at the Centre for Cancer Immunology in the University of Southampton: Targeting FcRn for the therapy of autoimmune disease
Mitchell Ho, Senior Investigator and Deputy Chief of the Laboratory of Molecular Biology and Director of the Antibody Engineering Program at the Center for Cancer Research: Engineering Immunotoxins and CAR-T Cells for Cancer Therapy Using Nanobodies
Joy Zuchero, Director and Principal Scientist at Denali Therapeutics: The Transport Vehicle: Engineering the Fc and Utilizing the Brain Vasculature to Deliver CNS Therapeutics
The Antibody Series 2024 Sponsors
Thank you to our supporting sponsors:
Platinum: PipeBio, Thermo Fisher Scientific
Silver: Infors HT, Sphere Fluidics
We look forward to welcoming you to Madeira Island and welcoming our growing community online! Stay tuned to our LinkedIn for further announcements.